Abstract:This paper describes the characterization of solid lipid nanodispersions (SLN) prepared with a 1:1 mixture of theobroma oil and goat fat as the main lipid matrix and Phospholipon 90G (P90G) as a stabilizer heterolipid, using polysorbate 80 as the mobile surfactant, with a view to applying the SLN in drug delivery. The 1:1 lipid mixture and P90G constituting the lipid matrix was first homogeneously prepared by fusion. Thereafter, the SLN were formulated with a gradient of polysorbate 80 and constant lipid matrix concentration by melt-high pressure homogenisation. The SLN were characterized by time-resolved particle size analysis, zeta potential and osmotic pressure measurements, differential scanning calorimetry (DSC) and wide angle X-ray diffraction (WAXD). Transmission electron microscopy (TEM) and isothermal heat conduction microcalorimetry (IMC) which monitors the in situ crystallization were also carried out on the SLN containing P90G and 1.0 % w/w of polysorbate 80. The results obtained in these studies were compared with SLN prepared with theobroma oil with and without phospholipid. Particle size analysis of SLN indicated reduction in size with increase in concentration of mobile surfactant and was in the lower nanometer range after 3 months except SLN prepared without P90G or polysorbate 80. The lipid nanoparticles had negative potentials after 3 months. WAXD and DSC studies revealed low crystalline SLN after 3 months of storage except in WAXD of SLN formulated with 1.0 % w/w polysorbate 80. TEM micrograph of the SLN containing 1.0 % w/w polysorbate 80 revealed discrete particles whose sizes were in consonance with the static light scattering measurement. In situ crystallization studies in IMC revealed delayed crystallization of the SLN with 1.0 % w/w polysorbate 80. Results indicate lipid mixtures produced SLN with lower crystallinity and higher particle sizes compared with SLN prepared with theobroma oil alone with or without P90G, and would lead to higher drug incorporation efficiency when used in formulation of actives. Mixtures of theobroma oil and goat fat would be suitable for the preparation of nanostructured lipid carriers. SLN of theobroma oil containing phospholipid could prove to be a good ocular or parenteral drug delivery system considering the low particle size, particle size stability and in vivo tolerability of the component lipids. SLN prepared with lipid admixture, which had higher increase in d(90%) on storage are suitable for preparation of topical and transdermal products.

Nimodipine Loaded Lipid Nanospheres Prepared by Solvent Diffusion Method in a Drug Saturated Aqueous System

Single-component Solid Lipid Nanocarriers Prepared with Ultra-Long Chain Amphiphilic Lipids.

Preparation and Characterization of Nimodipine-Loaded Nanostructured Lipid Systems for Enhanced Solubility and Bioavailability

Diclofenac Sodium-Loaded Solid Lipid Nanoparticles Prepared by Emulsion/solvent Evaporation Method

Study on Pharmacokinetics and Bioavailability of Nimodipine Nanostructured Lipid Carrier in Rats

Study on the preparation of carboxymethyl chitosan-coated nimodipine nanoliposomes and their in vitro release

Modified Preparation Method and Characteristics of Nimodipine-Loaded PLGA Microspheres

Liquid Proliposomes of Nimodipine Drug Delivery System: Preparation, Characterization, and Pharmacokinetics

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Solid Lipid Nanoparticles Prepared by Solvent Diffusion Method in a Nanoreactor System

One-step Self-Assembled Nanomicelles for Improving the Oral Bioavailability of Nimodipine

Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.

Preparation of Nimodipine Nanosuspension by Wet Milling

Preparation and Characteristics of Monostearin Nanostructured Lipid Carriers

Preparation of Nimodipine Microemulsion and Its Quality Evaluation

In Vitro Dissolution Enhancement of Micronized L-Nimodipine by Antisolvent Re-Crystallization from Its Crystal Form H.

Preparation of N-Maleoylchitosan Nanocapsules for Loading and Sustained Release of Felodipine

Development of a Nanostructured Lipid Carrier (NLC) by a Low-Energy Method, Comparison of Release Kinetics and Molecular Dynamics Simulation

Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles.

Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization

[Preparation of Solid Lipid Nanoparticles by Solvent Diffusion Method].